|
|
Volumn 148, Issue 5, 2009, Pages 810-814
|
|
Serum sFas, Leptin, and VEGF in patients with ovarian cancer and benign tumors
a
a
a
|
|
Author keywords
Leptin; Ovarian cancer and benign tumors; Prognosis; SFas; VEGF
|
|
Indexed keywords
FAS ANTIGEN;
LEPTIN;
SOLUBLE FAS ANTIGEN;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
ADULT;
AGED;
ARTICLE;
ASCITES;
BENIGN TUMOR;
CANCER GROWTH;
CANCER RELAPSE;
CANCER STAGING;
CANCER SURVIVAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
OVARY CANCER;
PROGNOSIS;
PROTEIN BLOOD LEVEL;
ADULT;
AGED;
ANTIGENS, CD95;
FEMALE;
HUMANS;
LEPTIN;
MIDDLE AGED;
OVARIAN NEOPLASMS;
TUMOR MARKERS, BIOLOGICAL;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 77952091089
PISSN: 00074888
EISSN: None
Source Type: Journal
DOI: 10.1007/s10517-010-0823-5 Document Type: Article |
|
Times cited : (10)
|
|
References (12)
|
